Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement

被引:41
作者
Shen, Hong C. [1 ]
Ding, Fa-Xiang [1 ]
Wang, Siyi [1 ]
Deng, Qiaolin [1 ]
Zhang, Xiaoping [1 ]
Chen, Yuli [1 ]
Zhou, Gaochao [1 ]
Xu, Suoyu [1 ]
Chen, Hsuan-Shen [1 ]
Tong, Xinchun [1 ]
Tong, Vincent [1 ]
Mitra, Kaushik [1 ]
Kumar, Sanjeev [1 ]
Tsai, Christine [1 ]
Stevenson, Andra S. [1 ]
Pai, Lee-Yuh [1 ]
Alonso-Galicia, Magdalena [1 ]
Chen, Xiaoli [1 ]
Soisson, Stephen M. [1 ]
Roy, Sophie [1 ]
Zhang, Bei [1 ]
Tata, James R. [1 ]
Berger, Joel P. [1 ]
Colletti, Steven L. [1 ]
机构
[1] Merck & Co Inc, Merck Res Labs, Rahway, NJ 07065 USA
关键词
EPOXYEICOSATRIENOIC ACIDS; HYPERPOLARIZING FACTOR; BKCA CHANNELS; METABOLISM; ARTERIES;
D O I
10.1021/jm900725r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
4-Substituted piperidine-derived trisubstituted ureas are reported as highly potent and selective inhibitors for sEH. The SAR Outlines approaches to improve activity against sEH and reduce ion channel and CYP liability. With minimal off-target activity and a good PK profile, the benchmark 2d exhibited remarkable tit vitro ;and ex vivo target engagement. The customer entA-2d also elicited vasodilation effect in tat mesenteric artery.
引用
收藏
页码:5009 / 5012
页数:4
相关论文
共 20 条
[1]   Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKCa channels [J].
Archer, SL ;
Gragasin, FS ;
Wu, XC ;
Wang, SH ;
McMurtry, S ;
Kim, DH ;
Platonov, M ;
Koshal, A ;
Hashimoto, K ;
Campbell, WB ;
Falck, JR ;
Michelakis, ED .
CIRCULATION, 2003, 107 (05) :769-776
[2]   Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors [J].
Campbell, WB ;
Gebremedhin, D ;
Pratt, PF ;
Harder, DR .
CIRCULATION RESEARCH, 1996, 78 (03) :415-423
[3]   Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries [J].
Fisslthaler, B ;
Hinsch, N ;
Chataigneau, T ;
Popp, R ;
Kiss, L ;
Busse, R ;
Fleming, I .
HYPERTENSION, 2000, 36 (02) :270-275
[4]  
Fredricksen E., 2000, Journal of Asynchronous Learning Networks, V4, P1
[5]   Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids [J].
Gomez, GA ;
Morisseau, C ;
Hammock, BD ;
Christianson, DW .
PROTEIN SCIENCE, 2006, 15 (01) :58-64
[6]  
Hammock B.D., 1997, Comprehensive Toxicology, P283
[7]   DIFFERENTIAL INTERACTIONS OF CLONIDINE AND METHOXAMINE WITH THE POSTSYNAPTIC ALPHA-ADRENOCEPTOR OF RABBIT MAIN PULMONARY-ARTERY [J].
HOLCK, MI ;
JONES, CHM ;
HAEUSLER, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (02) :240-248
[8]   Orally bioavailable potent soluble epoxide hydrolase inhibitors [J].
Hwang, Sung Hee ;
Tsai, Hsing-Ju ;
Liu, Jun-Yan ;
Morisseau, Christophe ;
Hammock, Bruce D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (16) :3825-3840
[9]   An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension [J].
Imig, JD ;
Zhao, XY ;
Zaharis, CZ ;
Olearczyk, JJ ;
Pollock, DM ;
Newman, JW ;
Kim, IH ;
Watanabe, T ;
Hammock, BD .
HYPERTENSION, 2005, 46 (04) :975-981
[10]   Medicinal chemistry of hERG optimizations: Highlights and hang-ups [J].
Jamieson, Craig ;
Moir, Elizabeth M. ;
Rankovic, Zoran ;
Wishart, Grant .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (17) :5029-5046